Eagle Pharmaceuticals, Inc(NASDAQ:EGRX) 
Eagle Pharmaceuticals, Inc., a biotechnology pharmaceutical company, focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for ch...
Website: http://www.eagleus.com
Founded: 2007
Full Time Employees: 108
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.25
H 1.89
L 1.25
C 1.89
V 799
10EMA 1.89
20EMA 1.89
60EMA 1.89
120EMA 1.89
250EMA 1.89